Original news and analysis on international IP policy
Veteran public health advocate Els Torreele of Belgium has been named the new executive director of the high-profile Médecins Sans Frontières (MSF, Doctors Without Borders) Access Campaign, based in Geneva.
Intellectual Property Watch needs your financial support. As one of our readers, you know that IP-Watch plays a vital role in international policymaking on intellectual property and innovation through its independent, reliable, balanced and dedicated news coverage. But like other…
Thomas Cueni of Switzerland has been named the next director general of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Geneva-based organisation which represents the global research-based pharma industry.
Patent assertion entity (PAE) activity has skyrocketed in the past decade and much discussion has occurred around what to do in response to patent holders whose strategy is more focused on legal battles than innovating. One notable group has risen up to bring together global companies to address the PAE issue with a novel sharing approach. In an interview with Intellectual Property Watch, Ken Seddon, CEO and President of LOT Network, talks about the group's rapid growth, what's coming next, and how not to bring a squirt gun to a nuclear fight.
Pfizer Board Chairman and CEO Ian Read has been elected as the next president of the Geneva-based International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), a two-year role.
As 16 Asia and Pacific nations prepare to meet in Indonesia next week for the next round of negotiations for a large regional trade agreement called RCEP, more than 300 civil society groups signed a letter urging negotiators to reject efforts to bring in texts from the separate Trans-Pacific Partnership (TPP).
NAIROBI, Kenya -- A ruling this month by a Kenyan court that artists, performers and musicians cannot be compelled or forced to join a collective management organisation (CMO) to collect royalties on their behalf could spell doom for CMOs in the country, experts fear.
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) today announced that its director general is stepping down at the end of January.
When visual artists sell their work, they usually perceive a price for that work. If it is resold at a much higher price, some countries provide for a resale right, providing artists with resale royalties. In other countries, such a right does not exist, putting visual artists in a disadvantageous situation, particularly indigenous artists, whose work can become very valuable on the international art markets.
Q. Todd Dickinson is a shareholder at Polsinelli law firm, and was director of the United States Patent and Trademark Office (USPTO) under President Clinton, a former lead IP counsel for two Fortune 50 corporations, and most recently executive director of the American Intellectual Property Law Association (AIPLA). In an interview with Intellectual Property Watch on 18 November in the margins of the IP Dealmakers conference in New York, Dickinson discussed US prospects for national and international IP policy after the presidential election, changes in Geneva, reform of US IP law, and repairing relationships.